Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Lüsebrink

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Infection|March 27, 2022
Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnerable individualsVerena Schildgen, Jessica Lüsebrink, Oliver Schildgen
New Microbes and New Infections|June 6, 2022
Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)Verena Schildgen, Jessica Lüsebrink, Oliver Schildgen
Infection Control and Hospital Epidemiology|November 20, 2020
Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)Jessica Lüsebrink, Verena Schildgen, Oliver Schildgen
The Journal of Infection|December 27, 2022
Recommendation for broad use of Covid-19 mRNA vaccine boosters due to waning vaccine effectiveness is taking the easy way outVerena Schildgen, Jessica Lüsebrink, Oliver Schildgen
Expert Review of Anti-Infective Therapy|November 4, 2009
Novel therapies for an old virus: treatment of RSV infections in the 21st CenturyJessica Lüsebrink, Verena Schildgen, Oliver Schildgen
Pathogens (Basel, Switzerland)|January 20, 2021
Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based PerspectiveVerena Schildgen, Sabrina Demuth, Jessica Lüsebrink, et al.
Viruses|October 14, 2011
Human bocavirus - insights into a newly identified respiratory virusJessica Lüsebrink, Felix Wittleben, Verena Schildgen, et al.
Infection Control and Hospital Epidemiology|May 12, 2020
Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic use and save personal protective equipment and swabsMonika Malecki, Jessica Lüsebrink, Stefanie Teves, et al.
Biological Chemistry|November 4, 2006
Switch from actin alpha1 to alpha2 expression and upregulation of biomarkers for pressure overload and cardiac hypertrophy in taurine-deficient mouse heartUlrich Warskulat, Birgit Andrée, Jessica Lüsebrink, et al.
Personalized Medicine|May 20, 2018
Epidemiology of EML4-ALK translocations in a small, German non-small-cell lung cancer patient cohortVerena Schildgen, Vincenza Lochi, Jessica Lüsebrink, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Infection|March 27, 2022
Compulsary SARS-CoV-2 (booster-) vaccination in healthcare facilities can not replace personal protection measures while dealing with vulnerable individualsVerena Schildgen, Jessica Lüsebrink, Oliver Schildgen
New Microbes and New Infections|June 6, 2022
Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)Verena Schildgen, Jessica Lüsebrink, Oliver Schildgen
Infection Control and Hospital Epidemiology|November 20, 2020
Pooling is an insufficient strategy to avoid healthcare staff to patient transmission of severe acute respiratory coronavirus virus 2 (SARS-CoV-2)Jessica Lüsebrink, Verena Schildgen, Oliver Schildgen
The Journal of Infection|December 27, 2022
Recommendation for broad use of Covid-19 mRNA vaccine boosters due to waning vaccine effectiveness is taking the easy way outVerena Schildgen, Jessica Lüsebrink, Oliver Schildgen
Expert Review of Anti-Infective Therapy|November 4, 2009
Novel therapies for an old virus: treatment of RSV infections in the 21st CenturyJessica Lüsebrink, Verena Schildgen, Oliver Schildgen
Pathogens (Basel, Switzerland)|January 20, 2021
Limits and Opportunities of SARS-CoV-2 Antigen Rapid Tests: An Experienced-Based PerspectiveVerena Schildgen, Sabrina Demuth, Jessica Lüsebrink, et al.
Viruses|October 14, 2011
Human bocavirus - insights into a newly identified respiratory virusJessica Lüsebrink, Felix Wittleben, Verena Schildgen, et al.
Infection Control and Hospital Epidemiology|May 12, 2020
Pharynx gargle samples are suitable for SARS-CoV-2 diagnostic use and save personal protective equipment and swabsMonika Malecki, Jessica Lüsebrink, Stefanie Teves, et al.
Biological Chemistry|November 4, 2006
Switch from actin alpha1 to alpha2 expression and upregulation of biomarkers for pressure overload and cardiac hypertrophy in taurine-deficient mouse heartUlrich Warskulat, Birgit Andrée, Jessica Lüsebrink, et al.
Personalized Medicine|May 20, 2018
Epidemiology of EML4-ALK translocations in a small, German non-small-cell lung cancer patient cohortVerena Schildgen, Vincenza Lochi, Jessica Lüsebrink, et al.
Pageof 4